drugset / Trial / NCT05058924

Low Molecular Weight hEparin vs. Aspirin Post-partum

NCT05058924

Completed 30 enrolled Mount Sinai Hospital, Canada
RandomizedParallel-groupOpen-labelPrevention

Summary

This is single centre pilot, randomized controlled trial assessing postpartum prophylactic anticoagulation with 3 weeks of LMWH followed by 3 weeks of Aspirin compared to standard of care of prophylactic LMWH for 6 weeks at moderate to high risk of developing VTE.

Timeline

Start
2021-08-29
Primary completion
2024-02-29
Completion
2024-03-01

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Aspirin Small molecule 81 mg Oral
Comparator Dalteparin sodium Other / unclassified 5000 iu Subcutaneous
Comparator Enoxaparin sodium Other / unclassified 40 mg Subcutaneous
Comparator Tinzaparin Other / unclassified 4500 iu Subcutaneous